Table 4 Summary of miRNA target genes within the CNV subgroups and the miRNAs targeting the CNV genes

737

84 (11.5%)^a

MAPK signaling pathway

MIR-128A,MIR-128B,MIR-194,MIR-27A,MIR-27B,MIR-296,MIR-302A,MIR-302B,MIR-302C,MIR-302D,MIR-326,MIR-329,MIR-34A,MIR-34C,MIR-372,MIR-373,MIR-449,MIR-503,MIR-520A,MIR-520B,MIR-520C,MIR-520D,MIR-520E,MIR-526B,MIR-9,MIR-93

Lysosome

Insulin signaling pathway

Axon guidance

Huntington’s disease

Hedgehog signaling pathway

Endocytosis

N-Glycan biosynthesis

p53 signaling pathway

Progesterone-mediated oocyte maturation

838

87 (10.4%)^a

Neurotrophin signaling pathway

MIR-196A,MIR-196B,MIR-24,MIR-320,MIR-506,MIR-493,MIR-25,MIR-32,MIR-92,MIR-363,MIR-367,MIR-512-5P,MIR-302C,MIR-30A-5P,MIR-30C,MIR-30D,MIR-30B,MIR-30E-5P,MIR-485-3P

Renal cell carcinoma

MAPK signaling pathway

Pathways in cancer

Chronic myeloid leukemia

Chemokine signaling pathway

Long-term potentiation

ErbB signaling pathway

TGF-beta signaling pathway

Adherens junction

188

15 (8.1%)^a

Ubiquitin mediated proteolysis

MIR-193A,MIR-193B,MIR-495,MIR-302C,MIR-198

454

0^b

N/A

0

266

3 (1.1%)^b

N/A

MIR-526B